Markus Muschen

Markus Müschen, MD-PhD, is a physician-scientist at Yale University, where he serves as the Director of the Center of Molecular and Cellular Oncology and Chief of the Division of Basic Science of Yale Cancer Center. His research focuses on signal transduction and metabolic pathways in lymphoid malignancies and how they can be intercepted for the treatment of drug-resistant leukemia and lymphoma. Markus Müschen studied Medicine in Cologne, Germany and the Institut Pasteur in Paris, France. After his clinical training in hematology-oncology with Volker Diehl, he completed postdoctoral fellowships with Klaus Rajewsky and Janet Rowley. Before coming to Yale, Markus Müschen’s laboratory was at UCSF for seven years where he led the Hematological Malignancies Program at the UCSF Comprehensive Cancer Center. He is currently an HHMI Faculty Scholar, supported by an NCI Outstanding Investigator Award (R35) and serves as mentor for graduate students, clinical and postdoctoral fellows.